![]() In June 2023, the FDA's Vaccines and Related Biological Products Advisory Committee (VRBPAC) unanimously voted to recommend that the 2023-2024 formulation of the COVID-19 vaccines be updated to a monovalent COVID-19 vaccine with an XBB-lineage of the Omicron variant. Vaccination remains the best protection against COVID-19 related hospitalization and death. Individuals 65 years of age and older and individuals with moderately or severely immunocompromising conditions are at the greatest risk of severe COVID-19. In the United States, COVID-19-related deaths increased by approximately 18% between July 8, 2023, and August 26, 2023, while COVID-19 related hospitalizations increased by about 16% within a similar timeframe. 3,4ĭespite the end of the federal PHE period, SARS-COV-2 continues to develop with new variants causing rapid transmission. ![]() 2 While the government will continue to provide free at-home COVID-19 rapid tests, this fall marks the first time the COVID-19 vaccines will transition to the commercial market, private and public payers, and traditional pathways of procurement, distribution, and payment. During the Federal COVID-19 Public Health Emergency (PHE), which lasted from January 31, 2020, until May 11, 2023, the government provided needed services such as free community COVID-19 testing, treatment, and vaccination.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |